Join
Live feed
·
INSIDERFilingvia Quantisnow
Solid Biosciences Inc. logo

Director Ganot Ilan converted options into 15,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SLDB· Solid Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SLDB (Solid Biosciences Inc.) and more on Quantisnow.

Director Ganot Ilan converted options into 15,000 shares (SEC Form 4) | Quantisnow